IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 31, 2025 | Oct 31 8:25 PM | Geary Richard S | Proposed Sale | 126,168 | $75.10 | $9.5M | — | View → |
| Oct 30, 2025 | Oct 30 10:21 PM | Joseph Wender | Proposed Sale | 33,600 | $74.17 | $2.5M | — | View → |
| Oct 15, 2025 | Oct 15 8:10 PM | Devers Shannon L. | Proposed Sale | 15,670 | $75.00 | $1.2M | — | View → |
| Oct 15, 2025 | Oct 15 8:08 PM | PARSHALL B LYNNE | Proposed Sale | 5,000 | $71.74 | $358.7K | — | View → |
| Oct 14, 2025 | Oct 14 8:58 PM | Birchler Brian | Proposed Sale | 31,900 | $72.00 | $2.3M | — | View → |
| Oct 6, 2025 | Oct 6 10:24 PM | Monia Brett P | Proposed Sale | 437 | $69.26 | $30.3K | — | View → |
| Oct 6, 2025 | Oct 6 10:09 PM | Baroldi Joseph | Proposed Sale | 1,625 | $69.37 | $112.7K | — | View → |
| Oct 6, 2025 | Oct 6 10:01 PM | Swayze Eric | Proposed Sale | 6,849 | $69.02 | $472.7K | — | View → |
| Oct 2, 2025 | Oct 2 10:11 PM | O'NEIL PATRICK R. | Proposed Sale | 78,105 | $67.69 | $5.3M | — | View → |
| Oct 2, 2025 | Oct 2 9:43 PM | Baroldi Joseph | Proposed Sale | 15,000 | $68.01 | $1.0M | — | View → |
| Oct 1, 2025 | Oct 1 9:33 PM | Joseph Wender | Proposed Sale | 22,400 | $65.80 | $1.5M | — | View → |
| Oct 1, 2025 | Oct 1 8:39 PM | Swayze Eric | Proposed Sale | 27,114 | $66.00 | $1.8M | — | View → |
| Sep 30, 2025 | Sep 30 8:49 PM | Geary Richard S | Proposed Sale | 57,900 | $65.24 | $3.8M | — | View → |
| Sep 30, 2025 | Sep 30 8:39 PM | HOUGEN ELIZABETH L | Proposed Sale | 49,800 | $65.26 | $3.2M | — | View → |
| Sep 3, 2025 | Sep 3 9:31 PM | LOSCALZO JOSEPH | Proposed Sale | 16,000 | $60.15 | $962.4K | — | View → |
| Sep 3, 2025 | Sep 3 9:15 PM | O'NEIL PATRICK R. | Proposed Sale | 124,850 | $61.15 | $7.6M | — | View → |
| Sep 3, 2025 | Sep 3 8:54 PM | BENNETT C FRANK | Proposed Sale | 51,800 | $60.86 | $3.2M | — | View → |
| Sep 3, 2025 | Sep 3 8:37 PM | Baroldi Joseph | Proposed Sale | 45,000 | $59.09 | $2.7M | — | View → |
| Sep 3, 2025 | Sep 3 8:30 PM | Monia Brett P | Proposed Sale | 203,814 | $60.01 | $12.2M | — | View → |
| Sep 3, 2025 | Sep 3 8:21 PM | Devers Shannon L. | Proposed Sale | 3,162 | $61.02 | $193.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |